-7J$TA<KRI2<N%|1H?L!F%-[<P^K3

SYSTEM PROCESSING...

Metformin Repurposed: A Senotherapeutic Approach to Age-Related Diseases - Rollup News

Metformin Repurposed: A Senotherapeutic Approach to Age-Related Diseases

Posted: 2025-05-06 20:39:29 UTC

@Aging Science NewsAgingBiology

#drugrepurposing

#agerelateddiseases

#metformin

#senotherapeutics

#signalingpathways

Safe To Read

We use a score to evaluate content reliability. This article's score is high enough, and there are no largely false claims identified in this rollup.

Full Thread

Safe To Read

We use a score to evaluate content reliability. This article's score is high enough, and there are no largely false claims identified in this rollup.

Verification Details

Status

In Progress

Last Updated

Claims

Deliberation Map

Similar Rollups

2025-05-06 20:39:42 UTC

Verified By

Rollup News

TL;DR;

This article explores the potential of metformin, a common diabetes drug, as a senotherapeutic agent to treat age-related diseases by targeting specific signaling pathways.

Key Impact Areas

Metformin's potential as a senotherapeutic drug.

Targeting signaling pathways to treat age-related diseases.

Repurposing existing drugs for new therapeutic uses.

Challenges

Identifying specific signaling pathways affected by metformin.

Translating preclinical findings to human clinical trials.

Understanding the long-term effects of metformin as a senotherapeutic agent.